Rapoport Sarah K, Smith Alyssa J, Bergman Maxwell, Scriven Kelly A, Brook Itzhak, Mikula Suzette K
Medstar Georgetown University Hospital, Department of Otolaryngology, Head & Neck Surgery, Washington DC, USA.
Mayo Clinic, Department of Otolaryngology, Head & Neck Surgery, Rochester, MN, USA.
World J Otorhinolaryngol Head Neck Surg. 2019 Jan 3;5(2):82-87. doi: 10.1016/j.wjorl.2018.11.001. eCollection 2019 Jun.
To demonstrate DNA sequencing analysis (DNAsa) of sinus cultures in patients with CRS is a reliable method of detecting pathogens in polymicrobial CRS infections.
After obtaining Institutional Review Board approval for this prospective cohort study, we selected a random sample of 50 patients with CRS at Medstar Georgetown University Hospital between September 2016 and March 2017. We defined CRS as a history of rhinosinusitis refractory to maximal medical therapy and prior endoscopic sinus surgery. Patients demonstrating active purulence in a sinus cavity were prospectively selected to undergo standard hospital cultures (SHC) and DNAsa cultures. Organisms identified in both methods were compared for each patient.
Specimens were obtained from 29 female and 16 male patients with a mean age of 50 years. A total of 45 cultures were included in our final analysis; five cultures were excluded after inappropriate laboratory processing. Results from these patients were compared and analyzed. Cohen's weighted analysis showed agreement between the two testing methods in identifying predominant microorganisms. DNAsa detected 31.9% more microorganisms compared to SHC ( < 0.05). When multiple microorganisms were detected, DNAsa yielded more positive results compared to SHC ( < 0.05).
DNAsa detects all microorganisms identified by SHC as well as predominant microorganisms not detected by SHC. Thus molecular pathogen identification may be more reliable for identifying multiple microorganisms as compared to standard culture techniques that identify only one or two microorganisms. In recalcitrant cases of CRS, DNAsa may provide better guidance in selection of appropriate antimicrobial treatment.
证明对慢性鼻-鼻窦炎(CRS)患者的鼻窦培养物进行DNA测序分析(DNAsa)是检测多微生物CRS感染中病原体的可靠方法。
在获得机构审查委员会对这项前瞻性队列研究的批准后,我们于2016年9月至2017年3月在Medstar乔治敦大学医院随机抽取了50例CRS患者。我们将CRS定义为对最大程度的药物治疗和先前的内镜鼻窦手术难治的鼻窦炎病史。前瞻性选择鼻窦腔内有活动性脓性分泌物的患者接受标准医院培养(SHC)和DNAsa培养。对每位患者两种方法鉴定出的微生物进行比较。
标本取自29名女性和16名男性患者,平均年龄50岁。我们的最终分析纳入了45份培养物;5份培养物因实验室处理不当被排除。对这些患者的结果进行了比较和分析。科恩加权分析显示两种检测方法在鉴定主要微生物方面具有一致性。与SHC相比,DNAsa检测到的微生物多31.9%(P<0.05)。当检测到多种微生物时,与SHC相比,DNAsa产生的阳性结果更多(P<0.05)。
DNAsa能检测出SHC鉴定出的所有微生物以及SHC未检测出的主要微生物。因此,与仅鉴定一两种微生物的标准培养技术相比,分子病原体鉴定在鉴定多种微生物方面可能更可靠。在CRS的难治性病例中,DNAsa可能为选择合适的抗菌治疗提供更好的指导。